Literature DB >> 17532115

Prospective validation of active surveillance in prostate cancer: the PRIAS study.

Roderick C N van den Bergh, Stijn Roemeling, Monique J Roobol, Wouter Roobol, Fritz H Schröder, Chris H Bangma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17532115     DOI： 10.1016/j.eururo.2007.05.011

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  58 in total

1.  [Patterns of care of patients with localized prostate cancer in Germany: a health care study with focus on active surveillance].

Authors:  F K H Chun; A Becker; L A Kluth; D Seiler; D Schnell; M Fisch; M Graefen; L Weissbach
Journal:  Urologe A       Date:  2015-01       Impact factor: 0.639

2.  Guidelines are too important to be left to clinical experts.

Authors:  Mattias Johansson; Pär Stattin
Journal:  CMAJ       Date:  2011-12-19       Impact factor: 8.262

3.  Utility of Gleason pattern 4 morphologies detected on transrectal ultrasound (TRUS)-guided biopsies for prediction of upgrading or upstaging in Gleason score 3 + 4 = 7 prostate cancer.

Authors:  Trevor A Flood; Nicola Schieda; Daniel T Keefe; Rodney H Breau; Chris Morash; Kevin Hogan; Eric C Belanger; Kien T Mai; Susan J Robertson
Journal:  Virchows Arch       Date:  2016-07-10       Impact factor: 4.064

4.  Diffusion-weighted magnetic resonance imaging for prediction of insignificant prostate cancer in potential candidates for active surveillance.

Authors:  Tae Heon Kim; Jae Yong Jeong; Sin Woo Lee; Chan Kyo Kim; Byung Kwan Park; Hyun Hwan Sung; Hwang Gyun Jeon; Byong Chang Jeong; Seong Il Seo; Hyun Moo Lee; Han Yong Choi; Seong Soo Jeon
Journal:  Eur Radiol       Date:  2015-01-31       Impact factor: 5.315

5.  Predictive role of free prostate-specific antigen in a prospective active surveillance program (PRIAS).

Authors:  Hanna Vasarainen; Jolanda Salman; Heidi Salminen; Riccardo Valdagni; Tom Pickles; Chris Bangma; Monique J Roobol; Antti Rannikko
Journal:  World J Urol       Date:  2015-03-31       Impact factor: 4.226

6.  Diagnostic prostate biopsy performed in a non-academic center increases the risk of re-classification at confirmatory biopsy for men considering active surveillance for prostate cancer.

Authors:  L M Wong; S Ferrara; S M H Alibhai; A Evans; T Van der Kwast; G Trottier; N Timilshina; A Toi; G Kulkarni; R Hamilton; A Zlotta; N Fleshner; A Finelli
Journal:  Prostate Cancer Prostatic Dis       Date:  2014-12-09       Impact factor: 5.554

7.  Prostate cancer-specific anxiety in Dutch patients on active surveillance: validation of the memorial anxiety scale for prostate cancer.

Authors:  Roderick C N van den Bergh; Ida J Korfage; Gerard J J M Borsboom; Ewout W Steyerberg; Marie-Louise Essink-Bot
Journal:  Qual Life Res       Date:  2009-08-09       Impact factor: 4.147

Review 8.  Active surveillance or active treatment in localized prostate cancer?

Authors:  Lothar Weissbach; Jens Altwein
Journal:  Dtsch Arztebl Int       Date:  2009-05-29       Impact factor: 5.594

9.  Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer.

Authors:  E A M Heijnsdijk; A der Kinderen; E M Wever; G Draisma; M J Roobol; H J de Koning
Journal:  Br J Cancer       Date:  2009-11-10       Impact factor: 7.640

10.  Current strategies for monitoring men with localised prostate cancer lack a strong evidence base: observational longitudinal study.

Authors:  C Metcalfe; K Tilling; M Davis; J A Lane; R M Martin; H Kynaston; P Powell; D E Neal; F Hamdy; J L Donovan
Journal:  Br J Cancer       Date:  2009-07-14       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.